Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,210 results that match your search.22,210 results
  • Pirates and counterfeiters are not always hardened criminals. MIP profiles some of the common, and less common, people involved in IP crime and asks: what makes them difficult to attack and what is the best approach to stopping them?
  • Singapore courts tend to adopt a strict approach to the exclusion of added subject matter when amending a patent or patent application. Hence, does a disclaimer, introduced into a patent claim in order to restore novelty over the prior art by excluding from its scope one or more particular examples in the prior art, constitute unallowable added subject matter under Singapore law if such a disclaimer has no basis in the application as originally filed?
  • AstraZeneca is using cutting-edge technology in a bid to keep counterfeits out of the supply chain. Emma Barraclough finds out how its new system will work
  • Counterfeiting is the scourge of IP owners. But if they are to tackle the problem effectively, they need to understand why people disregard their IP rights and ensure they are using the latest enforcement techniques. MIP provides a guide. Peter Ollier, Emma Barraclough, James Nurton and Shahnaz Mahmud
  • US patent litigation is governed by what is known as the American Rule. The American Rule is that attorney fees are not awardable to the winning party (that is, each litigant must pay his own attorney fees) unless statutorily or contractually authorized. In patent infringement litigation, Section 285 of the Patent Act provides the statutory exception but only in exceptional cases. It states that the "court in exceptional cases may award reasonable attorney fees to the prevailing party". An award of attorneys' fees under Section 285, however, is only available in "limited circumstances" and "is an exception to the American Rule" (Forest Labs, Inc v Abbott Labs, 339 F3d 1324, 1329 (Fed Cir 2003)).
  • If IP owners want to maximize their chances of having an application for a biotech or chemical invention granted in China, they need to pay careful attention to their test data, says Amy Feng of Liu Shen & Associates
  • Qingfa Meng and Bin Zhang of CCPIT explain how IP owners can make the most of Customs and the AIC in their trade mark enforcement strategies
  • China's patent legislation makes it very difficult for applicants to amend patent documents during a patent invalidation procedure. Scott S Zhang and Changxing Zhang of Kangxin Partners provide a guide to the rules
  • Companies that include Chinese patents in their multinational patent portfolios can expect to gain many strategic advantages, say Lily Lim and Ningling Wang of Finnegan Henderson Farabow Garrett & Dunner LLP
  • Benjamin Bai, Peter Wang and Tony Chen of Jones Day explain how to enforce a patent in the world's most litigious country for patent disputes